Denosumab (Prolia, Xgeva, biosimilars) — medical necessity and prior authorization criteria
Customize your policy alerts
Sign up for Moda Health Policy M-0098 alerts
Get alerted when Policy M-0098 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity, dosing limits, authorization periods, and coverage criteria for denosumab products for members in scope of Moda Health. Applies to providers requesting prior authorization for denosumab formulations listed in the policy.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.